Clinical trial

Lapatinib and Circulating Tumor Cells in Breast Cancer

NCT00694252

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-07-01

PhasePHASE2

Study timeline

Study start (unknown)2008-07-01Date precision: month

Registry last updated2015-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Breast Cancerunresolved

Interventions

LapatinibDRUG · verified · RxNorm: lapatinib

Sponsors & collaborators

University Hospital of Cretelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00694252 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.